AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 124 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $767,000 | +12.3% | 82,705 | -7.3% | 0.00% | – |
| Q2 2020 | $683,000 | +19.4% | 89,213 | -3.7% | 0.00% | – |
| Q1 2020 | $572,000 | -62.3% | 92,670 | -25.7% | 0.00% | – |
| Q4 2019 | $1,519,000 | -1.9% | 124,775 | -7.0% | 0.00% | – |
| Q3 2019 | $1,549,000 | +24.5% | 134,152 | +2.8% | 0.00% | – |
| Q2 2019 | $1,244,000 | -27.3% | 130,445 | -1.9% | 0.00% | – |
| Q1 2019 | $1,712,000 | -88.5% | 132,911 | -86.4% | 0.00% | -100.0% |
| Q4 2018 | $14,881,000 | -28.6% | 979,676 | -6.0% | 0.00% | -25.0% |
| Q3 2018 | $20,848,000 | -23.8% | 1,042,384 | -25.7% | 0.00% | -33.3% |
| Q2 2018 | $27,342,000 | +21.1% | 1,402,176 | +25.1% | 0.01% | +20.0% |
| Q1 2018 | $22,584,000 | +94.1% | 1,120,816 | +27.6% | 0.01% | +150.0% |
| Q4 2017 | $11,638,000 | +20.0% | 878,381 | +60.8% | 0.00% | 0.0% |
| Q3 2017 | $9,695,000 | -7.4% | 546,166 | -4.0% | 0.00% | 0.0% |
| Q2 2017 | $10,473,000 | -47.3% | 569,214 | -35.4% | 0.00% | -60.0% |
| Q1 2017 | $19,870,000 | -33.0% | 881,134 | +3.4% | 0.01% | -28.6% |
| Q4 2016 | $29,653,000 | +196.4% | 852,088 | +108.7% | 0.01% | +250.0% |
| Q3 2016 | $10,006,000 | -4.1% | 408,247 | -6.4% | 0.00% | -33.3% |
| Q2 2016 | $10,438,000 | +51.6% | 436,319 | +48.3% | 0.00% | +50.0% |
| Q1 2016 | $6,885,000 | -18.5% | 294,235 | +5.2% | 0.00% | 0.0% |
| Q4 2015 | $8,445,000 | -29.6% | 279,747 | -7.4% | 0.00% | -33.3% |
| Q3 2015 | $12,003,000 | -20.7% | 302,088 | +37.9% | 0.00% | -25.0% |
| Q2 2015 | $15,133,000 | +27.7% | 219,133 | +1.1% | 0.00% | +33.3% |
| Q1 2015 | $11,850,000 | +677.0% | 216,789 | +505.7% | 0.00% | – |
| Q4 2014 | $1,525,000 | -66.4% | 35,789 | -74.9% | 0.00% | -100.0% |
| Q3 2014 | $4,543,000 | -9.6% | 142,367 | -41.3% | 0.00% | 0.0% |
| Q2 2014 | $5,025,000 | -22.8% | 242,505 | -27.9% | 0.00% | -50.0% |
| Q1 2014 | $6,507,000 | -74.6% | 336,305 | -68.1% | 0.00% | -71.4% |
| Q4 2013 | $25,584,000 | +25.5% | 1,053,768 | +11.0% | 0.01% | +16.7% |
| Q3 2013 | $20,384,000 | +12.2% | 949,253 | +16.3% | 0.01% | 0.0% |
| Q2 2013 | $18,166,000 | – | 816,520 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |